...
首页> 外文期刊>Evidence-based dentistry >Legitimate to extrapolate efficacy from one pain context to another.
【24h】

Legitimate to extrapolate efficacy from one pain context to another.

机译:合法地将功效从一种疼痛环境推算到另一种疼痛环境。

获取原文
获取原文并翻译 | 示例
           

摘要

DATA SOURCES: Sources of literature were Medline, Embase, the Cochrane Library, Biological Abstracts and the Oxford Pain Relief Database. STUDY SELECTION: Randomised, double-blind trials were chosen that compared aspirin, ibuprofen or paracetamol with placebo in adult patients who had initially moderate or severe postoperative pain, and which measured pain intensity and relief using standard measurement tools over 4-6 h. DATA EXTRACTION AND SYNTHESIS: Criteria for inclusion were: full peer-reviewed journal publication; randomised controlled trials that included single-dose treatment groups of aspirin, ibuprofen or paracetamol and placebo; double-blind design; baseline pain of moderate to severe intensity; patients over 15 years of age; at least 10 patients per group; and the pain outcome measures of total pain relief (TOTPAR) or summed pain intensity difference (SPID) over 4-6 h, or sufficient data to allow their calculation. Pain measures permitted for the calculation of TOTPAR or SPID were a standardfive-point pain relief scale (none, slight, moderate, good, complete), a standard four-point pain intensity scale (none, mild, moderate, severe) or a standard visual analogue scale (VAS) for pain relief or pain intensity. Also accepted were the top two categories of a standard five-point global outcome scale (poor, fair, good, very good, excellent). RESULTS: Results from 160 comparisons of an analgesic versus placebo were included. These comprised 68 trials of aspirin at doses of 600/650 mg; 49 trials of ibuprofen at a dose of 400 mg; 19 trials of paracetamol at 600/650 mg; and 24 trials of paracetamol at 1000 mg. Dental studies predominated, forming 102 of the 160 studies (64%). There were no consistent differences between dental and postsurgical pain in single-dose trials of aspirin, either of two doses of paracetamol, or ibuprofen, where sufficiently large data sets exist to test the hypothesis. Only three out of 16 comparisons produced a statistically significant difference. CONCLUSIONS: A systematic difference in the estimate of analgesic efficacy between dental and postsurgical pain models remains unproven and, on balance, no major difference is likely.
机译:数据来源:文献来源为Medline,Embase,Cochrane图书馆,生物文摘和牛津疼痛缓解数据库。研究选择:选择随机,双盲试验,将阿司匹林,布洛芬或扑热息痛与安慰剂用于初次中度或重度术后疼痛的成年患者,并使用标准测量工具在4-6小时内测量疼痛强度和缓解情况。数据提取与综合:纳入标准为:同行评议的期刊全文出版;随机对照试验,包括阿司匹林,布洛芬或扑热息痛和安慰剂的单剂量治疗组;双盲设计;中度至重度基线疼痛; 15岁以上的患者;每组至少10名患者;以及4-6小时内的总疼痛缓解(TOTPAR)或总疼痛强度差异(SPID)的疼痛结果度量,或有足够的数据可以进行计算。可以用于计算TOTPAR或SPID的疼痛度量标准为五点疼痛缓解量表(无,轻度,中度,良好,完全),标准四点疼痛强度量表(无,轻度,中度,重度)或标准视觉模拟量表(VAS),用于缓解疼痛或减轻疼痛强度。标准五点全球结果量表的前两类(差,中,好,很好,非常好)也被接受。结果:包括从镇痛药和安慰剂的160个比较的结果。这些研究包括600/650 mg剂量的68项阿司匹林试验。布洛芬400毫克剂量的49项试验;对乙酰氨基酚600/650 mg的19个试验;和24项对乙酰氨基酚的1000毫克试验。牙科研究占主导地位,在160项研究中占102项(64%)。在单剂量阿司匹林试验(两种剂量的对乙酰氨基酚或布洛芬)中,牙科疼痛和术后疼痛之间没有一致的差异,因为存在足够大的数据集来检验该假设。 16个比较中只有3个产生了统计学上的显着差异。结论:牙科和手术后疼痛模型之间在止痛效果评估上的系统差异尚未得到证实,总的来说,可能没有重大差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号